Comparative Pharmacology
Head-to-head clinical analysis: CYCLAPEN W versus PENTIDS 200.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CYCLAPEN W versus PENTIDS 200.
CYCLAPEN-W vs PENTIDS '200'
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Cyclacillin is a beta-lactam antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), leading to cell lysis and death. It has a similar spectrum to ampicillin but with increased acid stability and oral absorption.
Penicillin G is a beta-lactam antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), thereby inhibiting transpeptidation and activating autolytic enzymes.
250-500 mg orally every 6 hours for mild to moderate infections; 500 mg orally every 6 hours for severe infections.
Penicillin G benzathine: 1.2 million units intramuscularly as a single dose.
None Documented
None Documented
0.5-1 hour in adults with normal renal function; prolonged to 2-6 hours in renal impairment.
0.5-1 hour; prolonged in renal impairment; anuric patients up to 10 hours
Primarily renal (90-100% unchanged via glomerular filtration and tubular secretion); minor biliary/fecal elimination (<10%).
Renal: 60-90% unchanged; biliary/fecal: 10-40%
Category C
Category C
Penicillin Antibiotic
Penicillin Antibiotic